Jingjing Li

2PUBLICATIONS
2CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jun 28, 2021
Efficacy and safety of anti-PD-1 inhibitor combined with nab-paclitaxel in Chinese patients with refractory melanoma.

Jing-Jing Li, Jiu-Hong Wang, Ya Dingv

Pageof 1

Frequent Collaborators

1 joint publications

Xiao-Shi Zhang

1 joint publications

Xing Zhang